10.1128/spectrum.00170-22 20 BurcelinR.SerinoM.ChaboC.GaridouL.PomiC.CourtneyM.et al (2013)
Organizations that cover GLP-1 drugs for weight loss typically do so through one of three ways: a prescription drug within a medical plan (85%), a dedicated weight management vendor point solution (12%) or a supplemental drug rider (4%)
following repeal in 1933, Goldring reopened the business with his son's help in 1939
Tianze Jiao, with first author CoDES trainee Fanxing Du, uses nationwide Medicare data and found that, among older adults with type 2 diabetes on stable levothyroxine therapy, initiation of GLP-1 receptor agonists was associated with a 46% increase on the risk of atrial fibrillation/flutter compared with initiation of SGLT2 inhibitors, while no significant difference was observed for stroke risk
a review count this small means each individual review swings the score meaningfully, and the sample is too small to generalize from
References World Health Organization (WHO)